Literature DB >> 28601415

Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers.

Hartmut Wekerle1.   

Abstract

T cells play a critical role in autoimmune diseases in the brain, particularly in multiple sclerosis (MS). Since T cells are normally prevented from crossing the blood-brain barrier (BBB), autoimmunity requires prior activation of naturally occurring autoreactive T cells in peripheral tissue. Recently, a critical role for the microbiota in this activation process has emerged. Here, we review the role of gut-associated lymphoid tissues (GALT) as a major site for the phenotypic changes that allow the migration of autoreactive T cells to the brain. Additionally, we examine the involvement of the microbiota in clinical MS as well as other brain disorders such as Parkinson's disease (PD), stroke, and psychiatric disorders.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28601415     DOI: 10.1016/j.it.2017.03.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  40 in total

Review 1.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

Review 2.  The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".

Authors:  Anne-Katrin Pröbstel; Sergio E Baranzini
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

3.  The Alzheimer's Disease-Associated Protein BACE1 Modulates T Cell Activation and Th17 Function.

Authors:  Gerard Hernandez-Mir; Itay Raphael; Shankar Revu; Catherine H Poholek; Lyndsay Avery; William F Hawse; Lawrence P Kane; Mandy J McGeachy
Journal:  J Immunol       Date:  2019-06-17       Impact factor: 5.422

Review 4.  Gut reactions: How the blood-brain barrier connects the microbiome and the brain.

Authors:  Aric F Logsdon; Michelle A Erickson; Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-23

Review 5.  Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 6.  Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.

Authors:  Bert A 't Hart
Journal:  Primate Biol       Date:  2019-05-10

Review 7.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

8.  Artificial Sweeteners Negatively Regulate Pathogenic Characteristics of Two Model Gut Bacteria, E. coli and E. faecalis.

Authors:  Aparna Shil; Havovi Chichger
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

Review 9.  Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets.

Authors:  Maria Elisa Perez-Muñoz; Scott Sugden; Hermie J M Harmsen; Bert A 't Hart; Jon D Laman; Jens Walter
Journal:  iScience       Date:  2021-06-10

10.  Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Authors:  R Hohlfeld
Journal:  Mult Scler       Date:  2021-05-28       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.